Jupiter Topco LLC bought a new position in Envista Holdings Corporation (NYSE:NVST – Free Report) in the second quarter, according to the company in its most recent disclosure with the SEC. The fund bought 480,349 shares of the company’s stock, valued at approximately $12,658,000. Jupiter Topco LLC owned 0.30% of Envista at the end of the most recent quarter.
Other hedge funds have also added to or reduced their stakes in the company. Royal Bank of Canada grew its holdings in shares of Envista by 26.6% in the first quarter. Royal Bank of Canada now owns 23,240 shares of the company’s stock worth $401,000 after acquiring an additional 4,885 shares during the period. Millennium Management LLC lifted its holdings in Envista by 218.6% in the first quarter. Millennium Management LLC now owns 383,966 shares of the company’s stock valued at $6,627,000 after acquiring an additional 263,442 shares during the period. Goldman Sachs Group Inc. boosted its position in Envista by 39.3% in the first quarter. Goldman Sachs Group Inc. now owns 629,140 shares of the company’s stock worth $10,859,000 after purchasing an additional 177,630 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its position in Envista by 15.5% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 568,982 shares of the company’s stock worth $9,821,000 after purchasing an additional 76,246 shares during the last quarter. Finally, Prudential Financial Inc. grew its stake in shares of Envista by 22.1% during the 2nd quarter. Prudential Financial Inc. now owns 18,785 shares of the company’s stock valued at $367,000 after purchasing an additional 3,395 shares during the period.
Envista Stock Down 1.1%
NVST opened at $27.15 on Friday. The stock has a market cap of $4.36 billion, a price-to-earnings ratio of 46.81, a price-to-earnings-growth ratio of 1.29 and a beta of 0.86. The company has a debt-to-equity ratio of 0.47, a quick ratio of 2.07 and a current ratio of 2.43. The firm’s fifty day moving average is $27.12 and its 200 day moving average is $26.38. Envista Holdings Corporation has a fifty-two week low of $18.77 and a fifty-two week high of $30.42.
Analyst Upgrades and Downgrades
Several equities analysts have recently weighed in on NVST shares. Piper Sandler reiterated a “neutral” rating and issued a $28.00 price objective (up from $26.00) on shares of Envista in a research note on Thursday, August 6th. Evercore restated an “outperform” rating and set a $33.00 target price on shares of Envista in a research report on Thursday, May 7th. Weiss Ratings raised shares of Envista from a “hold (c-)” rating to a “hold (c)” rating in a report on Thursday, August 6th. Morgan Stanley set a $23.00 price target on shares of Envista in a research report on Thursday, August 6th. Finally, BMO Capital Markets began coverage on shares of Envista in a research note on Wednesday, July 8th. They set a “market perform” rating and a $27.00 price target on the stock. One research analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating and nine have assigned a Hold rating to the stock. According to data from MarketBeat, Envista currently has an average rating of “Moderate Buy” and a consensus price target of $29.31.
Get Our Latest Analysis on NVST
Insider Buying and Selling at Envista
In related news, SVP Mischa Reis sold 8,000 shares of the firm’s stock in a transaction on Thursday, August 20th. The shares were sold at an average price of $27.50, for a total transaction of $220,000.00. Following the completion of the transaction, the senior vice president directly owned 27,321 shares of the company’s stock, valued at approximately $751,327.50. This trade represents a 22.65% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Corporate insiders own 0.99% of the company’s stock.
Envista Company Profile
Envista Holdings Corporation is a global dental products company that develops, manufactures and markets a broad portfolio of dental consumables, equipment and technology solutions. Headquartered in Brea, California, Envista serves dental practitioners, specialists and laboratories in more than 150 countries. The company’s offerings span implant, orthodontic, endodontic and restorative product lines as well as digital imaging systems and practice management software.
Envista’s product brands include Nobel Biocare for dental implants and restorative solutions, Ormco for orthodontic appliances and treatment systems, Kerr for restorative and endodontic materials, KaVo for dental imaging and handpieces, and Vista for surgical drills and instruments.
Further Reading
- Five stocks we like better than Envista
- From SaaS-pocalypse to Perfect Storm: Workday’s AI Growth Story Strengthens
- These 3 GARP Stocks Show Why Growth and Value Do Not Have to Clash
- Venture Into High-Volatility Corners of the Market With These 3 ETFs
- 3 Retail Stocks to Watch After a Big Consumer Earnings Week
Receive News & Ratings for Envista Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envista and related companies with MarketBeat.com's FREE daily email newsletter.
